The Global Ophthalmology Drugs Market Research report analyses important market trends from 2015 to 2022. Latest Innovations and Key Players in Ophthalmology Drugs Industry have also been discussed in the report. The diseases covered in the report include Glaucoma, Age-Related Macular Degeneration, Diabetic Macular Edema, Diabetic Retinopathy and Dry Eye Syndrome. Their etiology, pathophysiology, epidemiology patterns; key marketed drugs and medicines; key pipeline innovations have been included in the report. Pipeline Portfolio, licensing and co-development of major pharmaceutical companies in the Ophthalmology Drugs market have also been analysed in the research report.
Angiogenesis inhibitors are the most effective and most common therapies used in ophthalmology; this class of compounds has been the most commercially successful in the past decade, with products such as Eylea and Lucentis generating strong annual revenues. Although there are many generics available across the majority of ophthalmology disorders, there are a number of premium products that attract substantial revenues – in particular Eylea, Lucentis, Lumigan and Restasis.
Browse more detail information about the Global Ophthalmology Drugs Market Research report at: http://www.absolutereports.com/global-ophthalmology-drugs-market-to-2022-angiogenesis-modulators-and-gene-therapies-to-boost-overall-revenue-within-the-forecast-period-10274106
Pipeline Portfolio, Key marketed products, revenue, market share, latest licensing and co-development deals of following companies have been covered in the research report:
- Spark Therapeutics
Get a PDF Sample of Global Ophthalmology Drugs Market Research report at: http://www.absolutereports.com/enquiry/request-sample/10274106
Although there is a high degree of failure and uncertainty within the R&D of ophthalmology drugs, the number of drugs in the pipeline is very high, at 734. The majority of pipeline products are novel active pharmaceutical ingredients, with only a small proportion of products being either generics or repositioned from other indications. This shows progression in terms of the variety of different molecules being developed as therapeutic agents within the ophthalmology pipeline. The expected growth of the ophthalmology market over the forecast period is attributed to the approval of new drugs, as well as rising prevalence.
Scope of the Global Ophthalmology Drugs Market Research report:
– Global revenues for the ophthalmology market are forecast to grow at a compound annual growth rate of 9.48%, from $13.7 billion in 2015 to $26 billion in 2022. Which drugs will achieve blockbuster status and how will the key player companies perform during the forecast period?
– The ophthalmology pipeline is large and diverse, and contains 734 products. How does the composition of the pipeline compare with that of the existing market?
– What mechanisms of action and molecule types are most commonly being trialed in pipeline products in the various key indications?
– Which products will contribute to market growth most significantly, and which will achieve blockbuster status?
– Will the current market leaders retain their dominance over the forecast period, and how is their revenue share of the dermatology market set to change?
Have any query? ask our expert @ http://www.absolutereports.com/enquiry/pre-order-enquiry/10274106
Reasons to purchase this report:
This report will allow you to –
– Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis, and the treatment options available at each stage of diagnosis
– Visualize the composition of the ophthalmology market across each indication, in terms of dominant molecule types and targets, highlighting the key commercial assets and players
– Analyse the ophthalmology pipeline and stratify by stage of development, molecule type and molecular target, with a granular breakdown across key indications
– Understand the growth in patient epidemiology and market revenues for the ophthalmology market, globally and across the key players and product types
– Stratify the market in terms of the split between generic and premium products, and assess the role of these product types in the treatment of the various ophthalmology disorders.
– Identify commercial opportunities in the urological cancer deals landscape by analysing trends in licensing and co-development deals
Main Points from Detailed TOC of Global Ophthalmology Drugs Market to 2022 – Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period:
- Ophthalmology Drugs Industry Introduction
- Key Marketed Products
- Key Marketed Products
- Multi-Scenario Market Forecast to 2022
- Company Analysis and Positioning
- Strategic Consolidations
No. of Report Pages: 150
Price (Single User Licence): $4995
Get Discount on Global Ophthalmology Drugs Market Research Report at: http://www.absolutereports.com/enquiry/request-discount/10274106
About Absolute Report:
Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters.
Mr. Ameya Pingaley
+1-408 520 9750
Email – email@example.com